Applied dna reports third quarter fiscal 2023 financial results and provides corporate update

Conference call/webcast scheduled for today at 4:30 pm et stony brook, ny / accesswire / august 10, 2023 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced consolidated financial results for the third quarter of fiscal 2023 ended june 30, 2023. "our fiscal third quarter performance stands out for the substantial progress made to advance the development and commercialization of our lineardna™ platform for biotherapeutic applications that culminated shortly after the close of the quarter with our acquisition of spindle biotech and launch of our linea™ ivt platform for mrna production," stated dr. james a.
APDN Ratings Summary
APDN Quant Ranking